PR Newswire Clinical TrialsOriginal article
Cancer Drug Spending Is Headed Past $400 Billion as Colorectal and Pancreatic Cancers Move Up the Research Agenda
Neutral
AI Analysis
Summary
IQVIA Institute reports global cancer drug spending reached $252 billion in 2024 and forecasts it will exceed $400 billion by 2028, with the US representing approximately 46% of spending. Colorectal and pancreatic cancers are noted as moving up the research agenda.
Financial Highlights
Revenue
$252 billion in 2024, forecast to exceed $400 billion by 2028
Guidance
Global cancer medicine spending forecast to exceed $400 billion by 2028, with US accounting for 46% of total
Importance:2/10
Sentiment:
0.00
market analysiscancer drugsspending forecastcolorectal cancerpancreatic cancer
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on October 14, 2026 8:07 AM